AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 65 filers reported holding AMRYT PHARMA PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 8,857,268 | $61,292,000 | 22.96% |
| Stonepine Capital Management, LLC | 6,227,733 | $43,096,000 | 19.37% |
| MPM ASSET MANAGEMENT LLC | 2,668,843 | $18,468,000 | 7.03% |
| Aquilo Capital Management, LLC | 1,998,993 | $13,833,000 | 4.99% |
| New Leaf Venture Partners, L.L.C. | 449,737 | $3,112,000 | 1.85% |
| Global Frontier Investments LLC | 505,000 | $3,495,000 | 1.77% |
| Rubric Capital Management LP | 3,600,000 | $24,912,000 | 1.26% |
| Telemetry Investments, L.L.C. | 123,000 | $851,000 | 1.09% |
| Nantahala Capital Management | 1,437,458 | $9,947,000 | 0.64% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 6,333,552 | $43,828,000 | 0.62% |